The ASAIO Journal, published by Lippincott Williams & Wilkins, stands as a premier platform in the realm of bioengineering and biomedical innovation, with a rich history spanning from 1978 to present. Renowned for its rigorous peer-reviewed content, the journal holds an impressive impact factor categorized as Q1 in Biomedical Engineering and Q1 in Biophysics for 2023, signaling its critical role in advancing knowledge and research in these pivotal fields. The journal's domain extends into diverse topics within biophysics, biomaterials, and miscellaneous areas of medicine, making it a vital resource for researchers, professionals, and students alike. Through its commitment to showcasing pioneering research and fostering scientific dialogue, the ASAIO Journal reinforces its position as a key contributor to the ongoing development of innovative medical solutions. Researchers and practitioners can access a wealth of knowledge that is essential for staying at the forefront of technology and methodologies that shape the future of healthcare.

Vestnik Transplantologii i Iskusstvennyh Organov, published by the Federal Research Center Transplantology & Artificial Organs V I Shumakov, is an esteemed open access journal that has been disseminating critical research in the fields of transplantation and immunology since 2009. With an ISSN of 1995-1191 and E-ISSN 2412-6160, this journal serves as a vital resource for academics and practitioners alike, offering insights into current trends, innovations, and methodologies in organ transplantation. The journal is indexed in prominent databases, holding a Q4 category in Immunology and Allergy and a Q3 in Transplantation as of 2023, ranking 42nd out of 54 in the field of Medicine - Transplantation, and 208th out of 233 in Medicine - Immunology and Allergy. Through its commitment to open access publishing and its strategic focus on advancing the science of transplantology, Vestnik Transplantologii i Iskusstvennyh Organov contributes significantly to the global body of knowledge, promoting collaboration and engagement among researchers, healthcare professionals, and students from around the world.

Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

Biofabrication, published by IOP Publishing Ltd, stands at the forefront of the interdisciplinary fields of biochemistry, bioengineering, biomaterials, biomedical engineering, biotechnology, and miscellaneous medicine. Since its inception in 2009, this prestigious journal has secured its position within the Q1 category across multiple disciplines as of 2023, reflecting its high impact and significant contribution to advancing research in these domains. With ranks such as #19 in biochemistry and #10 in biomaterials according to Scopus, it showcases groundbreaking studies and innovative methodologies that are crucial for the evolution of biofabrication technologies. Authored by leading researchers and professionals, the journal publishes articles that explore the synthesis, characterization, and application of biomaterials, providing valuable insights for both academic researchers and industry practitioners. The impact factor of the journal, combined with its rigorous peer-review process, guarantees high-quality content that pushes the boundaries of knowledge and technology. Researchers and students engaged in these dynamic fields will find Biofabrication an indispensable resource for staying abreast of critical developments and emerging trends.

Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.

Biomedical Engineering Online, published by BMC, is an esteemed open-access journal in the United Kingdom that has been advancing the field of biomedical engineering since its inception in 2002. With a commitment to disseminating high-quality research, the journal encompasses a broad scope, including innovative studies in biomaterials, imaging technologies, and medical applications. Recognized within the Q2 quartile for various categories such as Biomaterials and Biomedical Engineering, it ranks favorably among its peers: Rank #58 out of 333 in Radiology, and Rank #15 out of 63 in Radiological and Ultrasound Technology in the Scopus database. These rankings, coupled with an open-access model, ensure that critical advancements in medical technology are accessible to researchers, health professionals, and students globally. As it continues through its converged years from 2002 to 2024, Biomedical Engineering Online remains an invaluable resource for anyone involved in the cutting-edge intersection of engineering and medicine.

International Journal of Artificial Organs is a prestigious peer-reviewed journal published by SAGE Publications Ltd, dedicated to advancing the field of bioengineering, biomaterials, and biomedical engineering. Established in 1978, the journal has a rich history of contributing to the research community with cutting-edge studies and advancements in artificial organ technology and related disciplines. With an impact factor that positions it in the Q3 category across multiple fields, including Medicine and Engineering, the journal serves as a vital resource for researchers, professionals, and students interested in innovative solutions for organ replacement and support. While it is not an open-access journal, it offers subscription-based access, ensuring the dissemination of high-quality research to stakeholders globally. Located in Italy, the journal’s scope encompasses a variety of disciplines, making it essential reading for those at the forefront of medical technology development. Explore the latest breakthroughs and join a community committed to transforming lives through science and engineering.

The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, published by WILEY, is a leading journal in the field of biomaterials and biomedical engineering, showcasing cutting-edge research that bridges the gap between material science and healthcare applications. With a robust 2023 impact factor reflecting its high-quality contributions, this journal is classified in the Q2 quartile for Biomaterials, Biomedical Engineering, and Ceramics and Composites, while achieving an impressive Q1 ranking in Metals and Alloys. The journal caters to a diverse readership, including researchers, professionals, and students, aiming to facilitate innovation and advancements in biocompatible materials and their applications in medical devices and tissue engineering. Access options for readers are available, ensuring the latest studies and findings are readily accessible to all stakeholders in this dynamic field. As it progresses towards its 2024 target, the JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A continues to be an essential resource for anyone involved in the development and application of biomedical materials.